Cologuard® is the easy, noninvasive colon cancer screening test you can use at home. It’s the only FDA-approved test that uses stool DNA technology and finds 92% of colon cancers1. Plus, it’s covered by Medicare and most major insurers.
If you’ve been putting off screening, and you’re 50 years of age or older at average risk for colon cancer, ask your healthcare provider today if this noninvasive option is right for you.
Did you know?
To learn more, visit CologuardTest.com
Cologuard is intended for the qualitative detection of colorectal neoplasia associated DNA markers and for the presence of occult hemoglobin in human stool. A positive result may indicate the presence of colorectal cancer (CRC) or advanced adenoma (AA) and should be followed by diagnostic colonoscopy. Cologuard is indicated to screen adults of either sex, 50 years or older, who are at typical average-risk for CRC. Cologuard is not a replacement for diagnostic colonoscopy or surveillance colonoscopy in high risk individuals.
Cologuard is not for high risk individuals, including those with a history of colorectal cancer and advanced adenoma, a family history of colorectal cancer, IBD or certain hereditary syndromes. Positive Cologuard results should be referred to diagnostic colonoscopy. A negative Cologuard test result does not guarantee absence of cancer or advanced adenoma. Following a negative result, patients should continue participating in a screening program at an interval and with a method appropriate for the individual patient. Cologuard performance when used for repeat testing has not been evaluated or established. Rx only.
†Statistic is applicable to colorectal cancer